BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 26337079)

  • 21. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
    Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncogenic role of DDX3 in breast cancer biogenesis.
    Botlagunta M; Vesuna F; Mironchik Y; Raman A; Lisok A; Winnard P; Mukadam S; Van Diest P; Chen JH; Farabaugh P; Patel AH; Raman V
    Oncogene; 2008 Jun; 27(28):3912-22. PubMed ID: 18264132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual inhibition of HCV and HIV by ring-expanded nucleosides containing the 5:7-fused imidazo[4,5-e][1,3]diazepine ring system. In vitro results and implications.
    Zhang N; Zhang P; Baier A; Cova L; Hosmane RS
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1154-7. PubMed ID: 24461293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation.
    Qin JJ; Wang W; Voruganti S; Wang H; Zhang WD; Zhang R
    Oncotarget; 2015 Feb; 6(5):2623-40. PubMed ID: 25739118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ezrin Binds to DEAD-Box RNA Helicase DDX3 and Regulates Its Function and Protein Level.
    Çelik H; Sajwan KP; Selvanathan SP; Marsh BJ; Pai AV; Kont YS; Han J; Minas TZ; Rahim S; Erkizan HV; Toretsky JA; Üren A
    Mol Cell Biol; 2015 Sep; 35(18):3145-62. PubMed ID: 26149384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient and tumor-specific knockdown of MTDH gene attenuates paclitaxel resistance of breast cancer cells both in vivo and in vitro.
    Yang L; Tian Y; Leong WS; Song H; Yang W; Wang M; Wang X; Kong J; Shan B; Song Z
    Breast Cancer Res; 2018 Sep; 20(1):113. PubMed ID: 30227879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of the anti-tumor activity of Methyl 2-(-5-fluoro-2-hydroxyphenyl)-1 H-benzo[d]imidazole-5-carboxylate against breast cancer in vitro and in vivo.
    Hasanpourghadi M; Pandurangan AK; Karthikeyan C; Trivedi P; Mustafa MR
    Oncotarget; 2017 Apr; 8(17):28840-28853. PubMed ID: 28392503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin analog B14 has high bioavailability and enhances the effect of anti-breast cancer cells in vitro and in vivo.
    Shen H; Shen J; Pan H; Xu L; Sheng H; Liu B; Yao M
    Cancer Sci; 2021 Feb; 112(2):815-827. PubMed ID: 33316116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Level of Murine DDX3 RNA Helicase Determines Phenotype Changes of Hepatocytes In Vitro and In Vivo.
    Sergeeva O; Abakumova T; Kurochkin I; Ialchina R; Kosyreva A; Prikazchikova T; Varlamova V; Shcherbinina E; Zatsepin T
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new protoapigenone analog RY10-4 induces apoptosis and suppresses invasion through the PI3K/Akt pathway in human breast cancer.
    Yuan Q; Cai S; Zhang X; Liu Z; Li Z; Luo X; Xiong C; Wang J; Hu J; Ruan J
    Cancer Lett; 2012 Nov; 324(2):210-20. PubMed ID: 22652174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance to everolimus driven by epigenetic regulation of MYC in ER+ breast cancers.
    Bihani T; Ezell SA; Ladd B; Grosskurth SE; Mazzola AM; Pietras M; Reimer C; Zinda M; Fawell S; D'Cruz CM
    Oncotarget; 2015 Feb; 6(4):2407-20. PubMed ID: 25537515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of DDX3 is directly modulated by hypoxia inducible factor-1 alpha in breast epithelial cells.
    Botlagunta M; Krishnamachary B; Vesuna F; Winnard PT; Bol GM; Patel AH; Raman V
    PLoS One; 2011 Mar; 6(3):e17563. PubMed ID: 21448281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 25-methoxyl-dammarane-3β, 12β, 20-triol and artemisinin synergistically inhibit MDA-MB-231 cell proliferation through downregulation of testes-specific protease 50 (TSP50) expression.
    Wang D; Zhao Y; Wang Y; Rong Y; Qin H; Bao Y; Song Z; Yu C; Sun L; Li Y
    Tumour Biol; 2016 Sep; 37(9):11805-11813. PubMed ID: 27039397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effective targeting of triple-negative breast cancer cells by PF-4942847, a novel oral inhibitor of Hsp 90.
    Mehta PP; Whalen P; Baxi SM; Kung PP; Yamazaki S; Yin MJ
    Clin Cancer Res; 2011 Aug; 17(16):5432-42. PubMed ID: 21715568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo inhibition of bone morphogenetic protein-2 on breast cancer cell growth.
    Ye S; Park BH; Song KJ; Kim JR; Jang KY; Park HS; Bae JS; Brochmann EJ; Wang JC; Murray SS; Lee KB
    Spine (Phila Pa 1976); 2013 Feb; 38(3):E143-50. PubMed ID: 23169070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silencing ARHGAP9 correlates with the risk of breast cancer and inhibits the proliferation, migration, and invasion of breast cancer.
    Wang T; Ha M
    J Cell Biochem; 2018 Sep; 119(9):7747-7756. PubMed ID: 29905031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Na⁺/H⁺ exchanger (NHE1) as a novel co-adjuvant target in paclitaxel therapy of triple-negative breast cancer cells.
    Amith SR; Wilkinson JM; Baksh S; Fliegel L
    Oncotarget; 2015 Jan; 6(2):1262-75. PubMed ID: 25514463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical roles of RNA helicase DDX3 and its interactions with eIF4E/PABP1 in stress granule assembly and stress response.
    Shih JW; Wang WT; Tsai TY; Kuo CY; Li HK; Wu Lee YH
    Biochem J; 2012 Jan; 441(1):119-29. PubMed ID: 21883093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic effect of DDX3 upregulation in distant breast cancer metastases.
    Heerma van Voss MR; Schrijver WA; Ter Hoeve ND; Hoefnagel LD; Manson QF; van der Wall E; Raman V; van Diest PJ;
    Clin Exp Metastasis; 2017 Jan; 34(1):85-92. PubMed ID: 27999982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.